or Try an Advanced Search...

    Technical Analysis for CPH - Cipher Pharmaceuticals Inc.

    Grade Last Price % Change Price Change
    B 8.500 -3.35% -0.295
    CPH closed down 3.35 percent on Friday, April 19, 2024, on 47 percent of normal volume.
    Earnings due: May 9
    *** please verify all earnings dates ***
    1 Watcher
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Weak or Absent Up Up Down
    Historical CPH trend table...
    Date Alert Name Type % Chg
    20 DMA Resistance Bearish 0.00%
    Outside Day Range Expansion 0.00%
    Gapped Up Strength 0.00%
    Down 3 Days in a Row Weakness 0.00%
    Down 4 Days in a Row Weakness 0.00%
    20 DMA Resistance Bearish -3.35%
    Down 3 Days in a Row Weakness -3.35%
    Gapped Down Weakness -3.35%
    Fell Below 20 DMA Bearish -3.63%
    Narrow Range Bar Range Contraction -3.63%
    Older End-of-Day Signals for CPH ...

       Recent Intraday Alerts

    Alert Time
    Fell Below Previous Day's Low about 11 hours ago
    Outside Day about 11 hours ago
    Down 3% about 13 hours ago
    Down 2% about 13 hours ago
    Rose Above Previous Day's High about 15 hours ago
    View Earlier Intraday Alerts

    Get a Trading Sidekick!

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Analyze My Stocks!
    Configure default chart indicators
    CPH Chart by TradingView
    Basic chart:

    Profile

    Cipher Pharmaceuticals Inc. Description

    Cipher Pharmaceuticals Inc. is a specialty pharmaceutical dermatology company. The Company has a portfolio of commercial and late-stage products. It operates in the specialty pharmaceuticals segment. It acquires products and compounds for treatment of various medical needs. Its commercial product portfolio includes ABSORICA; SITAVIG; NUVAIL; BIONECT; CLN8; INOVA; PRO:12 MOUSSE; AL12; LOTION UMECTA; ACLARO; EPURIS; VANIQA; ACTIKERALL; BETEFLAM; LIPOFEN; CONZIP, and DURELA. Its products treat indications, such as severe nodular acne, recurrent herpes labialis, nail dystrophy, dermal ulcers, mild/moderate onychomycosis, acne, dry skin, keratosis, hyperpigmentation, hyperkeratotic actinic keratosis and high cholesterol. Its pipeline of late-stage products includes DERMADEXIN, BETEFLAM PATCH, SITAVIG, PRURIDEXIN, OZENOXACIN, CF101 for plaque psoriasis, CF101 for rheumatoid arthritis, ASF-1096 and NANOLIPOLEE-007. It operates in Canada and the United States.

    Classification
    Sector: Healthcare
    Industry: Drug Manufacturers - Specialty & Generic
    Keywords: Medicine Pharma Pipe Pharmaceutical Pipeline RTT Skin Pharmaceuticals IPO Organ Systems Arthritis Ulcer Dermatology Nail Psoriasis Acne Actinic Keratosis Herpes Labialis Keratosis Onychomycosis Rheumatoid Arthritis

    Is CPH a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 3 bullish, 0 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Apr 3 Cipher Pharmaceuticals Announces Participation in the 2024 Bloom Burton & Co. Healthcare Investor Conference
    Mar 16 Cipher Pharmaceuticals' (TSE:CPH) three-year earnings growth trails the 93% YoY shareholder returns
    Mar 14 Cipher Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Results
    Mar 8 Cipher Pharmaceuticals Schedules Q4 2023 Earnings Release and Conference Call
    Jan 29 Cipher Pharmaceuticals Announces the Commencement of OTCQX Trading
    Jan 29 OTC Markets Group Welcomes Cipher Pharmaceuticals Inc. to OTCQX
    Nov 24 Cipher Pharmaceuticals Announces Change of Auditor
    Nov 15 Cipher Pharmaceuticals Announces Normal Course Issuer Bid
    Nov 15 Cipher Pharmaceuticals Inc.'s (TSE:CPH) 23% gain last week benefited both individual investors who own 56% as well as insiders
    Nov 9 Cipher Pharmaceuticals Reports Strong Sales & Earnings Growth in Q3 2023
    See more CPH news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 9.98
    52 Week Low 3.11
    Average Volume 50,938
    200-Day Moving Average 5.604
    50-Day Moving Average 7.938
    20-Day Moving Average 8.810
    10-Day Moving Average 8.789
    Average True Range 0.437
    RSI (14) 50.25
    ADX 24.19
    +DI 28.460
    -DI 23.604
    Chandelier Exit (Long, 3 ATRs) 8.669
    Chandelier Exit (Short, 3 ATRs) 9.211
    Upper Bollinger Bands 9.625
    Lower Bollinger Band 7.995
    Percent B (%b) 0.31
    BandWidth 18.495
    MACD Line 0.248
    MACD Signal Line 0.320
    MACD Histogram -0.0712
    Fundamentals Value
    Market Cap 229.75 Million
    Num Shares 27 Million
    EPS 0.28
    Price-to-Earnings (P/E) Ratio 30.04
    Price-to-Sales 0.85
    Price-to-Book 0.55
    PEG Ratio 0.00
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 9.265
    Resistance 3 (R3) 9.323 9.127 9.138
    Resistance 2 (R2) 9.127 8.932 9.098 9.095
    Resistance 1 (R1) 8.813 8.811 8.715 8.755 9.052
    Pivot Point 8.617 8.617 8.568 8.588 8.617
    Support 1 (S1) 8.303 8.422 8.205 8.245 7.948
    Support 2 (S2) 8.107 8.301 8.078 7.905
    Support 3 (S3) 7.793 8.107 7.863
    Support 4 (S4) 7.735